|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-23
|
|
pubmed:abstractText |
We sought to determine the incidence of and risk factors for thrombotic events early after discontinuing antithrombin therapy in patients with acute coronary syndromes.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
37
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1001-7
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11263599-Aged,
pubmed-meshheading:11263599-Antithrombins,
pubmed-meshheading:11263599-Creatine Kinase,
pubmed-meshheading:11263599-Creatine Kinase, MB Form,
pubmed-meshheading:11263599-Electrocardiography,
pubmed-meshheading:11263599-Female,
pubmed-meshheading:11263599-Heparin,
pubmed-meshheading:11263599-Hirudin Therapy,
pubmed-meshheading:11263599-Humans,
pubmed-meshheading:11263599-Isoenzymes,
pubmed-meshheading:11263599-Male,
pubmed-meshheading:11263599-Middle Aged,
pubmed-meshheading:11263599-Myocardial Infarction,
pubmed-meshheading:11263599-Randomized Controlled Trials as Topic,
pubmed-meshheading:11263599-Recombinant Proteins,
pubmed-meshheading:11263599-Recurrence,
pubmed-meshheading:11263599-Risk Factors,
pubmed-meshheading:11263599-Survival Rate,
pubmed-meshheading:11263599-Thrombolytic Therapy,
pubmed-meshheading:11263599-Thrombosis
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.
|
|
pubmed:affiliation |
Duke Clinical Research Institute, Durham, North Carolina 27715, USA. bahit001@mc.duke.edu
|
|
pubmed:publicationType |
Journal Article
|
